KCNN4 and aortic stenosis: Treatment with KCa3.1 channel blocker senicapoc reduces ACTA2 and COL1A1 mRNA expression, suggesting that blocking KCa3.1 may offer an unexplored therapeutic avenue for aortic stenosis.